Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol

International Journal of Pharmaceutics

Volumn 529, Issue 1-2, 2017, Pages 32-43

  Balguri, Sai Prachetan ^a   Adelli, Goutham R ^a   Janga, Karthik Yadav ^a   Bhagav, Prakash ^a   Majumdar, Soumyajit ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Chitosan chloride; Ciprofloxacin; PEG derivatized phospholipids; PEGylation; Surface functionalized NLCs; Topical lipid nanoparticles; Transcorneal penetration

Indexed keywords

CHITOSAN; CIPROFLOXACIN; MACROGOL; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PHOSPHOLIPID; UNCLASSIFIED DRUG; DRUG CARRIER; LIPID; MACROGOL DERIVATIVE; NANOPARTICLE;

ARTICLE; DENSITY; DISPERSITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; EYE INFECTION; EYE TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY;

CIPROFLOXACIN; DRUG CARRIERS; LIPIDS; MOLECULAR WEIGHT; NANOPARTICLES; POLYETHYLENE GLYCOLS;

EID: 85021187743     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.06.042     Document Type: Article

References (61)

1. Adelli, G.R., Balguri, S.P., Punyamurthula, N., Bhagav, P., Majumdar, S., Development and evaluation of prolonged release topical indomethacin formulations for ocular inflammation. Invest. Ophthalmol. Vis. Sci., 55(13), 2014, 463.
2. Adelli, G.R., Balguri, S.P., Majumdar, S., Effect of cyclodextrins on morphology and barrier characteristics of isolated rabbit corneas. AAPS PharmSciTech 16:5 (2015), 1220–1226.
3. Adelli, G.R., Hingorani, T., Punyamurthula, N., Balguri, S.P., Majumdar, S., Evaluation of topical hesperetin matrix film for back-of-the-eye delivery. Eur. J. Pharm. Biopharm. 92 (2015), 74–82.
4. Adelli, G.R., Balguri, S.P., Bhagav, P., Raman, V., Majumdar, S., Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery. Drug Deliv. 24:1 (2017), 370–379.
5. Allen, T.M., Hansen, C., Martin, F., Redemann, C., Yau-Young, A., Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066:1 (1991), 29–36.
6. Anderson, W., Kozak, D., Coleman, V.A., Jämting, Å.K., Trau, M., A comparative study of submicron particle sizing platforms: accuracy, precision and resolution analysis of polydisperse particle size distributions. J. Colloid Interface Sci. 405 (2013), 322–330.
7. Anon, Guidance for Industry Bioanalytical Method Validation. 2013 Available from: https://www.fda.gov/downloads/Drugs/Guidances/ucm368107.pdf.
8. Balguri, S.P., Adelli, G., Bhagav, P., Repka, M.A., Majumdar, S., Development of nano structured lipid carriers of ciprofloxacin for ocular delivery: characterization, in vivo distribution and effect of PEGylation. Invest. Ophthalmol. Vis. Sci., 56(7), 2015, 2269-.
9. Balguri, S.P., Adelli, G.R., Majumdar, S., Topical ophthalmic lipid nanoparticle formulations (SLN NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur. J. Pharm. Biopharm. 109 (2016), 224–235.
10. Barar, J., Aghanejad, A., Fathi, M., Omidi, Y., Advanced drug delivery and targeting technologies for the ocular diseases. Bioimpacts 6:1 (2016), 49–67.
11. ® — the first FDA-approved nano-drug: lessons learned. J. Control. Release 160:2 (2012), 117–134.
12. Chen, P., Chen, H., Zang, X., Chen, M., Jiang, H., Han, S., et al. Expression of efflux transporters in human ocular tissues. Drug Metab. Dispos. 41:11 (2013), 1934–1948.
13. Chen, Y., Ma, P., Gui, S., Cubic and hexagonal liquid crystals as drug delivery systems. BioMed Res. Int., 2014, 2014, 815981.
14. Cholkar, K., Patel, S.P., Vadlapudi, A.D., Mitra, A.K., Novel strategies for anterior segment ocular drug delivery. J. Ocul. Pharmacol. Ther. 29:2 (2013), 106–123.
15. Contreras-Ruiz, L., de la Fuente, M., Parraga, J.E., Lopez-Garcia, A., Fernandez, I., Seijo, B., et al. Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells. Mol. Vis. 17 (2011), 279–290.
16. De Campos, A.M., Sánchez, A., Gref, R., Calvo, P., Alonso, M., et al. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur. J. Pharm. Sci. 20:1 (2003), 73–81.
17. Fresta, M., Fontana, G., Bucolo, C., Cavallaro, G., Giammona, G., Puglisi, G., Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J. Pharm. Sci. 90:3 (2001), 288–297.
18. Gaudana, R., Ananthula, H.K., Parenky, A., Mitra, A.K., Ocular drug delivery. AAPS J. 12:3 (2010), 348–360.
19. Geroski, D.H., Edelhauser, H.F., Drug delivery for posterior segment eye disease. Invest. Ophthalmol. Vis. Sci. 41:5 (2000), 961–964.
20. Giannavola, C., Bucolo, C., Maltese, A., Paolino, D., Vandelli, M.A., Puglisi, G., et al. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm. Res. 20:4 (2003), 584–590.
21. He, C., Hu, Y., Yin, L., Tang, C., Yin, C., Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:13 (2010), 3657–3666.
22. Hosny, K.M., Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech. 11:1 (2010), 241–246.
23. P.K. Hui, W.R. Diluzio, Stabilization and terminal sterilization of phospholipid formulations Google Patents; 2002.
24. Hussain, A.H., Muhammad, Shoaib, Muhammad, Harris, Yousuf, Rabia Ismail, Shafi, Nigha, Bioanalytical method development and validation of ciprofloxacin by RP-HPLC method. Asian J. Pharm. Biol. Res., 2(4), 2012, 19.
25. Kakkar, S., Karuppayil, S.M., Raut, J.S., Giansanti, F., Papucci, L., Schiavone, N., et al. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. Int. J. Pharm. 495:1 (2015), 276–289.
26. Ke, T.L., Cagle, G., Schlech, B., Lorenzetti, O.J., Mattern, J., Ocular bioavailability of ciprofloxacin in sustained release formulations. J. Ocul. Pharmacol. Ther. 17:6 (2001), 555–563.
27. Kompella, U.B., Amrite, A.C., Pacha Ravi, R., Durazo, S.A., Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog. Retin. Eye Res. 36 (2013), 172–198.
28. Kou, L., Sun, J., Zhai, Y., He, Z., The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J. Pharm. Sci. 8:1 (2013), 1–10.
29. Kulkarni, S.A., Feng, S.S., Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 30:10 (2013), 2512–2522.
30. Li, W., Zhan, P., De Clercq, E., Lou, H., Liu, X., Current drug research on PEGylation with small molecular agents. Prog. Polym. Sci. 38:3–4 (2013), 421–444.
31. Lim, S.B., Banerjee, A., Onyuksel, H., Improvement of drug safety by the use of lipid-based nanocarriers. J. Control. Release 163:1 (2012), 34–45.
32. Lizunova, A., Loshkarev, A., Tokunov, Y.M., Ivanov, V., Comparison of the results of measurements of the sizes of nanoparticles in stable colloidal solutions by the methods of acoustic spectroscopy dynamic light scattering, and transmission electron microscopy. Meas. Tech., 2017, 1–5.
33. Müller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54:Suppl (2002), S131–S155.
34. Maeda, H., Bharate, G.Y., Daruwalla, J., Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 71:3 (2009), 409–419.
35. Martins, S., Sarmento, B., Ferreira, D.C., Souto, E.B., Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles. Int. J. Nanomed. 2:4 (2007), 595–607.
36. A.K. Mishra, Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations Google Patents; 2013.
37. Morlet, N., Graham, G.G., Gatus, B., McLachlan, A.J., Salonikas, C., Naidoo, D., et al. Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis. Antimicrob. Agents Chemother. 44:6 (2000), 1674–1679.
38. Patel, A., Cholkar, K., Agrahari, V., Mitra, A.K., Ocular drug delivery systems: an overview. World J. Pharmacol. 2:2 (2013), 47–64.
39. Pozzi, D., Colapicchioni, V., Caracciolo, G., Piovesana, S., Capriotti, A.L., Palchetti, S., et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale 6:5 (2014), 2782–2792.
40. Qaddoumi, M.G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., Lee, V.H.L., The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm. Res. 21:4 (2004), 641–648.
41. Rowe-Rendleman, C.L., Durazo, S.A., Kompella, U.B., Rittenhouse, K.D., Di Polo, A., Weiner, A.L., et al. Drug and gene delivery to the back of the eye: from bench to bedside. Invest. Ophthalmol. Vis. Sci. 55:4 (2014), 2714–2730.
42. Schilt, Y., Berman, T., Wei, X., Barenholz, Y., Raviv, U., Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs. Biochim. Biophys. Acta 1860:1 Pt A (2016), 108–119.
43. Sharma, P.K.S.P., Jaswanth, A., Chalamaiah, M., Tekade, K.R., Balasubramaniam, A., Novel encapsulation of lycopene in niosomes and assessment of its anticancer activity. J. Bioequivalence Bioavailab. 8:5 (2016), 224–232.
44. Singh, V.K., Singh, P.K., Sharma, P.K., Srivastava, P.K., Mishra, A., Formulation and evaluation of topical gel of acelofenac containing piparine. Indo-Am. J. Pharm. Res., 3(7), 2013, 5268.
45. Taha, E.I., El-Anazi, M.H., El-Bagory, I.M., Bayomi, M.A., Design of liposomal colloidal systems for ocular delivery of ciprofloxacin. Saudi Pharm. J. 22:3 (2014), 231–239.
46. Taha, E.I., Badran, M.M., El-Anazi, M.H., Bayomi, M.A., El-Bagory, I.M., Role of Pluronic F127 micelles in enhancing ocular delivery of ciprofloxacin. J. Mol. Liq. 199 (2014), 251–256.
47. Tiwari, R., Pathak, K., Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm. 415:1–2 (2011), 232–243.
48. Tosi, G., Vergoni, A.V., Ruozi, B., Bondioli, L., Badiali, L., Rivasi, F., et al. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: in vivo pharmacological evidence and biodistribution. J. Control. Release 145:1 (2010), 49–57.
49. Tuoriniemi, J., Johnsson, A.-C.J., Holmberg, J.P., Gustafsson, S., Gallego-Urrea, J.A., Olsson, E., et al. Intermethod comparison of the particle size distributions of colloidal silica nanoparticles. Sci. Technol. Adv. Mater., 15(3), 2014, 035009.
50. Uner, M., Yener, G., Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomed. 2:3 (2007), 289–300.
51. Vergoni, A.V., Tosi, G., Tacchi, R., Vandelli, M.A., Bertolini, A., Costantino, L., Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. Nanomedicine 5:4 (2009), 369–377.
52. Verhoef, J.J.F., Anchordoquy, T.J., Questioning the use of PEGylation for drug delivery. Drug Deliv. Transl. Res. 3:6 (2013), 499–503.
53. Veronese, F.M., Mero, A., The impact of PEGylation on biological therapies. BioDrugs 22:5 (2008), 315–329.
54. Veronese, F.M., Pasut, G., PEGylation, successful approach to drug delivery. Drug Discov. Today 10:21 (2005), 1451–1458.
55. Vij, N., Min, T., Marasigan, R., Belcher, C.N., Mazur, S., Ding, H., et al. Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J. Nanobiotechnol., 8(1), 2010, 22.
56. Woodle, M.C., Newman, M.S., Cohen, J.A., Sterically stabilized liposomes: physical and biological properties. J. Drug Target. 2:5 (1994), 397–403.
57. Woodle, M.C., Sterically stabilized liposome therapeutics. Adv. Drug Deliv. Rev. 16:2 (1995), 249–265.
58. Yellepeddi, V.K., Palakurthi, S., Recent advances in topical ocular drug delivery. J. Ocul. Pharmacol. Ther. 32:2 (2016), 67–82.
59. Yoon, G., Park, J.W., Yoon, I.-S., Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J. Pharm. Investig. 43:5 (2013), 353–362.
60. Zeng, N., Hu, Q., Liu, Z., Gao, X., Hu, R., Song, Q., et al. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability. Int. J. Pharm. 424:1–2 (2012), 58–66.
61. Zheng, J., Wan, Y., Elhissi, A., Zhang, Z., Sun, X., Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles. Pharm. Res. 31:8 (2014), 2220–2233.